Kraig Biocraft Laboratories (KBLB.OB) Advisory Board Member Dr. Malcolm Fraser Named “Inventor” of Pending Provisional Patent Technology
Kraig Biocraft Laboratories, Inc., a biotechnology company focused on the development of commercially significant high performance polymers and technical fiber, announced that a provisional patent application, with groundbreaking technology describing a platform for antigen presentation and antibody test kits, has been filed. The patent lists Dr. Malcolm Fraser of Notre Dame, a member of Kraig’s Scientific Advisory Board, and a scientific consultant to Kraig, as the named inventor. Dr. Malcolm Fraser explains, “The invention describes engineered polymers which incorporate diagnostic antigens. The genetically fused polymers can potentially be fashioned into a number of different diagnostic test platforms including serum (blood),…